These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33803)

  • 21. Preparation of 125I-labeled receptor-purified Graves' immunoglobulins: properties of their binding to human thyroid membranes.
    Endo K; Borges M; Amir S; Ingbar SH
    J Clin Endocrinol Metab; 1982 Sep; 55(3):566-76. PubMed ID: 6284786
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterisation of long-acting thyroid stimulator gamma-G binding protein.
    Smith BR
    Biochim Biophys Acta; 1971 Mar; 229(3):649-62. PubMed ID: 4929149
    [No Abstract]   [Full Text] [Related]  

  • 23. [Proceedings: Isolation of LATS-IgG by isoelectric point electrophoresis].
    Ochi Y; Yatani T; Yoshimura M; Miyazaki T; Kaimasu I
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):559. PubMed ID: 4476568
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoelectric focusing of long-acting thyroid stimulator immunoglobulin G.
    Lonergan C; Babiarz D; Burke G
    J Clin Endocrinol Metab; 1973 Mar; 36(3):439-44. PubMed ID: 4631063
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathogenesis of neonatal Graves' disease.
    McKenzie JM; Zakarija M
    J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyroid antigen stimulates lymphocytes from patients with Graves' disease to produce thyroid-stimulating immunoglobulin (TSI).
    Knox AJ; von Westarp C; Row VV; Volpé R
    J Clin Endocrinol Metab; 1976 Aug; 43(2):330-7. PubMed ID: 181397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
    Loeffler M; Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zoological specificity of human thyroid-stimulating antibody.
    Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1978 Aug; 47(2):249-54. PubMed ID: 45462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
    Ginsberg J; von Westarp C
    CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-acting thyroid stimulator and related factors.
    Kendall-Taylor P; Dirmikis SM; Munro DS
    Proc R Soc Med; 1975 Apr; 68(4):252-3. PubMed ID: 1242809
    [No Abstract]   [Full Text] [Related]  

  • 31. The production of thyroid-stimulating immunoglobulin (TSI) by lymphocytes from patients with Graves' disease cultured with human thyroid subcellular fractions.
    Sugenoya A; Trokoudes K; Row VV; Volpé R
    J Endocrinol Invest; 1978 Jul; 1(3):245-51. PubMed ID: 583156
    [No Abstract]   [Full Text] [Related]  

  • 32. Radioimmunological studies on the long-acting thyroid stimulator.
    Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
    Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
    [No Abstract]   [Full Text] [Related]  

  • 33. The eye changes of Graves' disease: overview.
    Werner SC
    Mayo Clin Proc; 1972 Dec; 47(12):969-74. PubMed ID: 4564711
    [No Abstract]   [Full Text] [Related]  

  • 34. The cytochemical bioassay for thyroid -stimulating antibody of Graves' disease: further experience.
    Loveridge N; Zakarija M; Bitensky L; McKenzie JM
    J Clin Endocrinol Metab; 1979 Oct; 49(4):610-5. PubMed ID: 582599
    [No Abstract]   [Full Text] [Related]  

  • 35. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM; Zakarija M; D'Amour P; Joasoo A
    N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
    Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
    J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves' immunoglobulin Gs assessed in the mouse.
    Shishiba Y; Ozawa Y; Ohtsuki N; Shimizu T
    J Clin Endocrinol Metab; 1982 Apr; 54(4):858-62. PubMed ID: 6277983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graves' immunoglobulin G stimulates iodide efflux in FRTL-5 thyroid cells.
    Shoda Y; Kondo Y; Kobayashi I
    J Clin Endocrinol Metab; 1993 Jul; 77(1):94-7. PubMed ID: 8100833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assays of thyroid-stimulating antibody.
    McKenzie JM; Zakarija M
    Methods Enzymol; 1985; 109():677-91. PubMed ID: 2859517
    [No Abstract]   [Full Text] [Related]  

  • 40. A new method for assessing the thyrotropin binding inhibitory activity in the immunoglobulins and whole serum of patients with Graves' disease.
    Borges M; Ingbar JC; Endo K; Amir S; Uchimura H; Nagataki S; Ingbar SH
    J Clin Endocrinol Metab; 1982 Mar; 54(3):552-8. PubMed ID: 6120179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.